Multi-cancer screening in APAC gains momentum amidst economic growth | Healthcare Asia Magazine
, APAC
Photo from Leohoho on Unsplash

Multi-cancer screening in APAC gains momentum amidst economic growth

The global market for multi-cancer screening is expected to reach $2.72b by 2030.

Asia-Pacific’s (APAC) economic growth has accelerated the deployment of multi-cancer screening technologies, according to a report by 360iResearch.

The report revealed that China’s economic incline has created a surge in healthcare spending, particularly on AI adoption and genetic testing innovations under the Healthy China 2030 plan.

Meanwhile, Japan’s healthcare strategy prioritises multi-cancer screening for early detection efforts.

ALSO READ: NUH to establish health centre for early cancer detection in 2025

Moreover, India is in the early stages of adopting the technology with its government initiatives such as the National Cancer Screening Program.

According to the report, multi-cancer screening utilises advances in liquid biopsies, genetic testing, and artificial intelligence (AI)  to facilitate timely and more effective treatment paths.

Its global market is expected to reach $2.72b at a compound annual growth rate (CAGR) of 9.9% by 2030.

 

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!